inTest Stock (AMEX:INTT), Trade Ideas

inTest

inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Short Ideas

Trading Ideas

INTT

On Monday, shares of Intest Corp (NYSE: INTT) experienced volatile short activity. After the activity, the stock price went down -1.9% to $23.25.

The overall sentiment for INTT has been Bullish.

Short Volatility Alert: Intest Corp

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

BLBX

CJJD

HTGM

PTPI

UIHC

WULF

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Tuesday.

Following the market opening Tuesday, the Dow traded down 0.12% to 33,945.01 while the NASDAQ rose 0.55% to 12,224.15. The S&amp;P 500, also rose, gaining, 0.37% to 4,166.85.

US Stocks Mixed; Housing Starts Edge Lower In March

EDBL

ETNB

GRIL

LKCO

VORB

ZFOX

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 75 points on Wednesday.

The Dow traded up 0.23% to 32,635.71 while the NASDAQ rose 0.65% to 11,932.62. The S&amp;P 500, also rose, gaining, 0.34% to 4,016.52.

Dow Rises 75 Points; Fed Increases Rates By 25bps

inTest Corp

Lake Street analyst Jaeson Schmidt maintains inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) with a Buy and lowers the price target from $19 to $16.

Price Target

Analyst Ratings

Lake Street Maintains Buy on inTest, Lowers Price Target to $16

Guidance

InTest Cuts FY24 Revenue From $145M-$155M To $140M-$150M Vs $149.797M Est.

InTest Sees Q2 2024 Adj. EPS $0.10-$0.16 Vs $0.20 Est.; Revenue $34M-$36M Vs $33.750M Est.

inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.09 by 11.11 percent. This is a 65.52 percent decrease over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $29.824 million which beat the analyst consensus estimate of $29.050 million by 2.66 percent. This is a 6.56 percent decrease over sales of $31.919 million the same period last year.

Earnings Beats

inTest Q1 2024 Adj EPS $0.10 Beats $0.09 Estimate, Sales $29.824M Beat $29.050M Estimate

WIIM

InTest shares are trading higher after the company reported better-than-expected adjusted EPS results.

inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) reported its Q4 earnings results on Wednesday, March 27, 2024 at 05:07 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
inTest beat estimated earnings by 23.0%, reporting an EPS of $0.16 versus an estimate of $0.13.
Revenue was down $4.52 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.03 which was followed by a 4.0% drop in the share price the next day.
Here's a look at inTest's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.25</td>
<td>0.27</td>
<td>0.26</td>
<td>0.32</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.28</td>
<td>0.28</td>
<td>0.29</td>
<td>0.34</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>32.65M</td>
<td>32.10M</td>
<td>31.06M</td>
<td>31.45M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>32.66M</td>
<td>32.56M</td>
<td>31.92M</td>
<td>32.41M</td>
</tr>
</tbody>
</table>

To track all earnings releases for inTest <a href="https://www.benzinga.com/quote/INTT/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: inTest Q4 Earnings

inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. The company reported quarterly sales of $27.884 million which missed the analyst consensus estimate of $29.152 million by 4.35 percent. This is a 13.95 percent decrease over sales of $32.405 million the same period last year.

Earnings Misses

inTest Q4 2023 Adj EPS $0.16 Beats $0.14 Estimate, Sales $27.884M Miss $29.152M Estimate

The restatement pertains to deferral of revenue related to purchases on behalf of certain customers associated with &quot;last time buys&quot; of discontinued material/components for potential future orders.&nbsp;Preliminary indications are that the&nbsp;third quarter&nbsp;2023 restatement is expected to result in a decrease in revenue of approximately&nbsp;$1.7 million.&nbsp;After giving effect to this change, earnings per diluted share for the&nbsp;third quarter&nbsp;2023 as previously reported is expected to be reduced from&nbsp;$0.24&nbsp;to&nbsp;$0.19.&nbsp;The deferral of revenue is also expected to have a small impact on previously announced preliminary&nbsp;fourth quarter&nbsp;results.&nbsp;Fourth quarter&nbsp;2023 revenue is now expected to be approximately&nbsp;$27.9 million&nbsp;with net earnings of&nbsp;$1.5 million, or&nbsp;$0.12&nbsp;per diluted share.

inTEST To Restate Q3 And First Nine Months 2023 Financial Statements; Expects To Report Material Weakness In Its Internal Control Over Financial Reporting

The acquisition is expected to be dilutive to earnings per diluted share in 2024, but accretive to non-GAAP adjusted EPS due to the anticipated impacts associated with the amortization of intangible assets. Given the timing of the acquisition, the impact to&nbsp;first quarter&nbsp;2024 results from operations are expected to be nominal.

inTEST Updates Full Year 2024 Guidance Due To Alfamation Acquisition; Boosts 2024 Revenue Outlook From $125M-$130M To $145M-$155M; Est $125.795M

Alfamation will become a part of the Electronic Test division within inTEST.&nbsp;At current exchange rates, Alfamation&#39;s annual revenue in 2023 was approximately&nbsp;$25 million&nbsp;and had backlog at December 31, 2023 of approximately&nbsp;$15 million. The Company expects the acquisition to be accretive in 2025. Alfamation has generated healthy, double-digit, annual revenue growth over the last few years.

inTEST Acquires Alfamation S.p.A.; No Terms Disclosed

<h3>Gainers</h3>
<ul>
<li>Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) shares moved upwards by 8.9% to $10.0 during Monday's after-market session. The market value of their outstanding shares is at $155.4 million. As per the news, the Q4 earnings report came out today. </li>
<li>Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) shares moved upwards by 5.96% to $13.15. The market value of their outstanding shares is at $103.5 million. </li>
<li>CommScope Hldg Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) stock moved upwards by 5.88% to $1.08. The company's market cap stands at $229.0 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
<li>Casa Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASA#NASDAQ">CASA</a>) stock moved upwards by 5.71% to $0.44. The market value of their outstanding shares is at $44.0 million. </li>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) stock moved upwards by 4.13% to $0.7. The company's market cap stands at $30.1 million. </li>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) stock rose 4.06% to $0.2. The company's market cap stands at $7.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) shares fell 11.6% to $65.85 during Monday's after-market session. The company's market cap stands at $10.2 billion. The company's, Q4 earnings came out today. </li>
<li>SEMrush Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) shares fell 7.7% to $12.0. The market value of their outstanding shares is at $1.7 billion. The company's, Q4 earnings came out today. </li>
<li>ARB IOT Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) stock decreased by 6.24% to $1.5. The company's market cap stands at $39.6 million. </li>
<li>MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares decreased by 5.82% to $1256.5. The company's market cap stands at $21.3 billion. </li>
<li>Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) stock declined by 4.95% to $0.33. The company's market cap stands at $26.8 million. </li>
<li>inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) shares decreased by 4.71% to $11.32. The company's market cap stands at $137.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ARBB

CASA

COMM

GTLB

INTZ

MSTR

PHUN

PRST

SEMR

SONM

12 Information Technology Stocks Moving In Monday's After-Market Session

inTEST Prelim. Q4 Revenue ~$28.4M, EPS $0.14, Sees Q1 Revenue $28M-$30M, EPS $0.08-$0.13; Co. To Reschedule Q4 Earnings Release

inTEST Delays Q4 2023 Earnings Release, Says it Requires Additional Time To Complete Year-end Audit And Review Process; Preliminary Q4 Revenue $28.4M, Est $29.152M

inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) is set to give its latest quarterly earnings report on Friday, 2024-03-01. Here's what investors need to know before the announcement.
Analysts estimate that inTest will report an earnings per share (EPS) of $0.13. 
inTest bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.03, which was followed by a 0.0% drop in the share price the next day.
Here's a look at inTest's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.25</td>
<td>0.27</td>
<td>0.26</td>
<td>0.32</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.28</td>
<td>0.28</td>
<td>0.29</td>
<td>0.34</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-10.0%</td>
<td>5.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709215292_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of inTest were trading at $11.53 as of February 27. Over the last 52-week period, shares are down 19.2%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/INTT/earnings">To track all earnings releases for inTest visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For inTest

<h3>Gainers</h3>
<ul>
<li>Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) stock increased by 9.1% to $1.91 during Tuesday's after-market session. The market value of their outstanding shares is at $474.0 million. </li>
<li>Red Cat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock rose 9.07% to $0.6. The company's market cap stands at $43.0 million. </li>
<li>Wrap Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRAP#NASDAQ">WRAP</a>) stock rose 4.95% to $2.33. The company's market cap stands at $103.0 million. </li>
<li>Inuvo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INUV#AMEX">INUV</a>) shares moved upwards by 3.32% to $0.34. The company's market cap stands at $47.2 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock rose 2.91% to $0.53. The market value of their outstanding shares is at $9.8 million. </li>
<li>ReAlpha Tech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) shares moved upwards by 2.66% to $2.31. The market value of their outstanding shares is at $101.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares fell 9.2% to $0.62 during Tuesday's after-market session. The market value of their outstanding shares is at $3.7 million. </li>
<li>Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) shares decreased by 5.01% to $0.6. The company's market cap stands at $40.4 million. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) shares declined by 4.33% to $1.77. The market value of their outstanding shares is at $4.9 million. </li>
<li>inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) stock decreased by 4.22% to $11.36. The company's market cap stands at $138.1 million. </li>
<li>LightPath Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTH#NASDAQ">LPTH</a>) stock declined by 3.63% to $1.33. The market value of their outstanding shares is at $49.8 million. </li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock decreased by 3.51% to $1.1. The company's market cap stands at $5.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRE

BLND

DGLY

INUV

LPTH

PBTS

RCAT

SOBR

SVRE

WRAP

12 Information Technology Stocks Moving In Tuesday's After-Market Session

Buybacks

inTEST Board Approves Stock Repurchase Plan For Up To $10M Of Common Stock Through November 17, 2024

$100,000,000 inTEST Corporation Common Stock Preferred Stock Warrants
Purchase Contracts
Rights Units
We may offer to the public from time to time in one or more series or issuances: shares of our common stock; shares of our preferred stock; warrants to purchases shares of our common stock and/or preferred stock; purchase contracts for the purchase of common stock, preferred stock or other securities; rights to purchase common stock, preferred stock, or other securities or other rights of the Company; units, consisting of common stock, preferred stock and/or warrants; or any combination of these securities.
This prospectus provides a general description of the securities that we may offer. Each time that securities are sold under this prospectus, we will provide specific terms of the securities offered in a supplement to this prospectus. The prospectus supplement may also add, update or change information contained in this prospectus. This prospectus may not be used to consummate a sale of securities unless accompanied by the applicable prospectus supplement. You should read both this prospectus and the applicable prospectus supplement together with additional information described under the heading "Where You Can Find More Information" before you make your investment decision.
Securities sold under this prospectus shall be sold directly to purchasers or through agents on our behalf or through underwriters or dealers as designated from time to time. If any agents or underwriters are involved in the sale of any of these securities, the applicable prospectus supplement will provide the names of the agents or underwriters and any applicable fees, commissions or discounts.
Our common stock is listed on NYSE American under the symbol "INTT." On November 8, 2023, the last reported sale price of our common stock reported on NYSE American was $12.04 per share. We will provide information in any applicable prospectus supplement regarding any listing of securities other than shares of our common stock on any securities exchange.&nbsp;

Offerings

inTEST Corp Files Prospectus For Up To $100M Offering

<h3>Companies Reporting Before The Bell</h3>
&bull; Arcutis Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQT#NASDAQ">ARQT</a>) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
&bull; Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) is expected to report quarterly earnings at $0.77 per share on revenue of $4.38 billion.
&bull; Atmus Filtration Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATMU#NYSE">ATMU</a>) is estimated to report quarterly earnings at $0.45 per share on revenue of $390.96 million.
&bull; Lovesac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $150.66 million.
&bull; Enbridge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENB#NYSE">ENB</a>) is likely to report quarterly earnings at $0.44 per share on revenue of $8.25 billion.
&bull; Oncolytics Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCY#NASDAQ">ONCY</a>) is likely to report earnings for its third quarter.
&bull; Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $987.00 million.
&bull; TELUS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TU#NYSE">TU</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $5.08 billion.
&bull; TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $657.82 million.
&bull; Bloomin Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $1.09 billion.
&bull; Restaurant Brands Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) is expected to report quarterly earnings at $0.86 per share on revenue of $1.88 billion.
&bull; Cinemark Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $834.58 million.
&bull; Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $702.46 million.
&bull; Icahn Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEP#NASDAQ">IEP</a>) is likely to report quarterly earnings at $0.34 per share on revenue of $2.71 billion.
&bull; Editas Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) is expected to report quarterly loss at $0.57 per share on revenue of $3.42 million.
&bull; Owens &amp; Minor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) is likely to report quarterly earnings at $0.35 per share on revenue of $2.58 billion.
&bull; iRadimed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRMD#NASDAQ">IRMD</a>) is likely to report quarterly earnings at $0.36 per share on revenue of $16.17 million.
&bull; Moog Inc. Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOG#NYSE">MOG</a>) is projected to report quarterly earnings at $1.71 per share on revenue of $806.33 million.
&bull; Lazydays Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZY#NASDAQ">LAZY</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $307.87 million.
&bull; Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) is expected to report earnings for its third quarter.
&bull; US Silica Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLCA#NYSE">SLCA</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $380.20 million.
&bull; Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) is expected to report earnings for its third quarter.
&bull; Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) is projected to report quarterly earnings at $1.96 per share on revenue of $1.39 billion.
&bull; Plains GP Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAGP#NASDAQ">PAGP</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $12.56 billion.
&bull; Plains All American (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $14.43 billion.
&bull; Sempra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>) is projected to report quarterly earnings at $1.00 per share on revenue of $3.68 billion.
&bull; American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $1.50 billion.
&bull; Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) is projected to report quarterly earnings at $1.86 per share on revenue of $479.89 million.
&bull; Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $3.89 billion.
&bull; Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $10.33 billion.
&bull; E W Scripps (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) is likely to report quarterly loss at $0.22 per share on revenue of $565.97 million.
&bull; Koppers Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOP#NYSE">KOP</a>) is likely to report quarterly earnings at $1.26 per share on revenue of $559.00 million.
&bull; Telephone and Data (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) is likely to report quarterly loss at $0.11 per share on revenue of $1.28 billion.
&bull; United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $1.00 billion.
&bull; W.P. Carey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPC#NYSE">WPC</a>) is likely to report quarterly earnings at $0.63 per share on revenue of $450.17 million.
&bull; GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) is expected to report earnings for its third quarter.
&bull; Rapid Micro Biosystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPID#NASDAQ">RPID</a>) is estimated to report quarterly loss at $0.31 per share on revenue of $5.55 million.
&bull; Shenandoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHEN#NASDAQ">SHEN</a>) is likely to report quarterly loss at $0.01 per share on revenue of $71.18 million.
&bull; AMC Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMCX#NASDAQ">AMCX</a>) is expected to report quarterly earnings at $1.28 per share on revenue of $657.80 million.
&bull; inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $32.65 million.
&bull; Proto Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NYSE">PRLB</a>) is projected to report quarterly earnings at $0.30 per share on revenue of $122.61 million.
&bull; FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) is expected to report quarterly loss at $0.32 per share on revenue of $286.18 million.
&bull; Gates Industrial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTES#NYSE">GTES</a>) is expected to report quarterly earnings at $0.31 per share on revenue of $877.78 million.
&bull; Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) is likely to report quarterly earnings at $1.41 per share on revenue of $54.76 billion.
&bull; AdvanSix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIX#NYSE">ASIX</a>) is projected to report quarterly loss at $0.03 per share on revenue of $367.90 million.
&bull; Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $25.32 million.
&bull; Corebridge Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) is expected to report quarterly earnings at $1.04 per share on revenue of $5.07 billion.
&bull; Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is expected to report quarterly loss at $0.33 per share on revenue of $63.41 million.
&bull; Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRP#NYSE">NRP</a>) is projected to report earnings for its third quarter.
&bull; Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) is expected to report quarterly loss at $0.26 per share on revenue of $164.80 million.
&bull; Northwest Natural Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWN#NYSE">NWN</a>) is likely to report quarterly loss at $0.67 per share on revenue of $134.78 million.
&bull; Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) is expected to report earnings for its third quarter.
&bull; Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $324.75 million.
&bull; Atlanta Braves Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BATRK#NASDAQ">BATRK</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $268.70 million.
&bull; Atlanta Braves Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BATRA#NASDAQ">BATRA</a>) is expected to report quarterly earnings at $0.32 per share on revenue of $268.50 million.
&bull; Qurate Retail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRTEB#NASDAQ">QRTEB</a>) is estimated to report earnings for its third quarter.
&bull; Qurate Retail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRTEA#NASDAQ">QRTEA</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $2.54 billion.
&bull; Liberty Formula One Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $900.58 million.
&bull; Liberty Formula One Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $895.00 million.
&bull; Liberty SiriusXM Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSXMK#NASDAQ">LSXMK</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $2.30 billion.
&bull; Liberty SiriusXM Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSXMA#NASDAQ">LSXMA</a>) is expected to report quarterly earnings at $0.85 per share on revenue of $2.30 billion.
&bull; Liberty Broadband (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDK#NASDAQ">LBRDK</a>) is estimated to report quarterly earnings at $2.43 per share on revenue of $257.00 million.
&bull; Liberty Broadband (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>) is expected to report quarterly earnings at $2.18 per share on revenue of $252.20 million.
&bull; GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) is projected to report quarterly loss at $0.03 per share on revenue of $180.00 million.
&bull; Church &amp; Dwight Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>) is projected to report quarterly earnings at $0.68 per share on revenue of $1.43 billion.
&bull; MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is projected to report quarterly earnings at $1.80 per share on revenue of $14.31 billion.
&bull; Brookfield Business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBUC#NYSE">BBUC</a>) is estimated to report earnings for its third quarter.
<h3>Companies Reporting After The Bell</h3>
&bull; Eversource Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>) is projected to report quarterly earnings at $0.99 per share on revenue of $3.29 billion.
&bull; Trinseo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSE#NYSE">TSE</a>) is likely to report quarterly loss at $0.96 per share on revenue of $973.00 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ACRE

AMCX

ARQT

ASIX

ATMU

BATRA

BATRK

BBUC

BEPC

BLMN

CBOE

CRBG

EDIT

FLGT

FUBO

FWONA

FWONK

GLYC

GTES

IRMD

LAZY

LBRDA

LBRDK

LOVE

LSXMA

LSXMK

ONCY

PAGP

PRLB

PRVA

QRTEA

QRTEB

RPID

SHEN

SLCA

TILE

TIXT

Earnings Scheduled For November 3, 2023

inTEST Sees Q4 Revenue Of $28M - $30M Vs. $32.4M Est; Adj EPS Of $0.12 - $0.17 Vs. $0.2 Est.

inTEST Cuts FY23 Revenue Guidance From $127M - $131M To $125M - $127M Vs. $129.5M Est.

Northland Securities analyst Ted Jackson reiterated a Buy rating on inTEST (INTT – Research Report) today and set a price target of $17.00. The com...

Northland Securities Reaffirms Their Buy Rating on inTEST (INTT)

Lake Street analyst Jaeson Schmidt reiterated a Buy rating on inTEST (INTT – Research Report) today and set a price target of $19.00. The company's...

Lake Street Sticks to Their Buy Rating for inTEST (INTT)

The Silicon Carbide Luster Is Gone For Axcelis And Other Semiconductor Supply Chain Vendors

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The stock market is facing some unique challenges at this point. For starters, the specter of inflation continues to push back the timelines for interest rate cuts that many had anticipated by now. Then there&rsquo;s the incredibly uncertain geopolitical situation due to the Ukraine and Middle East conflict. Furthermore, the artificial intelligence (AI) catalyst hasn&rsquo;t materialized as most expected. Hence, its probably not the best time to be thinking about the best $10 stocks



Consequently, the stock market is now in correction territory, with more pain in the upcoming weeks. Nevertheless, most analysts and the general public still believe in soft and no-landing scenarios. Moreover, according to Bank of America chairman and CEO&nbsp;<a target="_blank" href="https://finance.yahoo.com/video/bank-america-ceo-potential-soft-120035092.html">Brian Moynihan</a>, the Federal Reserve is one course to getting inflation to 2%. Therefore, within the next few months, we could be witnessing the start of a new bull run, which significantly adds to the attractiveness of these three best $10 stocks.



<h2>Best $10 Stocks: Grab (GRAB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/03/grab-300x169.jpg" alt="A group of Grab riders on motorbikes in Bangkok, Thailand."><div>Source: Twinsterphoto / Shutterstock.com</div></div>Grab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grab-stock-quote/">GRAB</a>) operates a ride-hailing platform and super app, effectively tapping into the mushrooming Southeast Asian middle class. Over the past several quarters, it has been an excellent performer, piquing investor interest last year, gaining more than 10%. However, it hasn&rsquo;t taken off the way its business has in the past couple of years.



It boasts a spotless record of revenue beats in the past eight consecutive quarters, <a href="https://www.cnbc.com/2024/02/23/grab-posts-first-profitable-quarter-announces-share-buyback.html">topping its first profitable quarter</a> at the end of last year. Its fourth-quarter (Q4) report showed its first profit, an incredible feat considering it posted a whopping $391 million in the prior-year period. Moreover, it is expected to grow at <a href="https://seekingalpha.com/news/4070151-grab-beats-top-line-and-bottom-line-estimates-initiates-fy24-outlook">a healthy 14% to 17%</a> this year, positioning it for substantial long-term gains.



A lot of it has to do with the dynamic market it operates in, which is poised to continue growing at a considerable pace. According to Boston Consulting Group, in 2020, ASEAN&rsquo;s middle class grew by 9% to 200 million, with a projected 5% annual increase in middle-income households through 2030.



<h2>inTest (INTT)</h2>



<div><img width="300" height="165" src="https://investorplace.com/wp-content/uploads/2017/07/inttmsn-300x165.jpg" alt=""><div>Source: Shutterstock</div></div>inTest&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/intt-stock-quote/" target="_blank">INTT</a>) is a tech firm with a lot of promise. It&rsquo;s a specialist in providing testing solutions for semiconductor manufacturers, focusing on integrated circuits and system-level assessments.



The semiconductor industry has been on fire in the past year or so, driven by the rapid advancements in AI. However, INTT stock remained out of favor with investors despite being a top performer in the past decade. In fact, <a href="https://seekingalpha.com/symbol/INTT/momentum/performance">its 181% gain</a> over the past 10 years surpasses the S&amp;P 500&rsquo;s 167% increase during the same period.



Nonetheless, InTest has shown robust progress despite the headwinds in the semiconductor space. Over the years, it has operated as a profitable enterprise, with a net loss on just one occasion in the past decade. Moreover, <a href="https://seekingalpha.com/symbol/INTT/profitability">its return on common equity and free cash flow (FCF)</a> margins are over 11.50%, respectively. Despite its solid profile, it&rsquo;s remarkably undervalued, with Tiprank&rsquo;s analysts predicting a 63% upside from current price levels.



<h2>Himax Technologies (HIMX)</h2>



<div><img width="300" height="165" src="https://investorplace.com/wp-content/uploads/2017/03/himxmsn-300x165.jpg" alt="Image of a green semiconductor board"><div>Source: Shutterstock</div></div>Himax Technologies&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/himx-stock-quote/">HIMX</a>) operates as a fabless semiconductor business, offering display-imaging processing technologies in China, Taiwan, and other countries. A fabless company like Himax effectively outsources the production of its chips to foundries, focusing its efforts on designing and selling the hardware.



It may not be a well-known name, but as InvestorPlace contributor Josh Enomoto notes, it&rsquo;s <a href="https://investorplace.com/2024/04/the-3-most-undervalued-tech-stocks-to-buy-in-april-2024/">a crucial &ldquo;backstage&rdquo; asset</a> in consumer electronics. During the pandemic, the company experienced robust sales growth mainly due to the heightened demand for consumer electronics. However, growth rates have slowed substantially since then, but it&rsquo;s judging its business based on the pandemic anomaly is unwise. Moreover, it beat analyst estimates in three of the past quarters on revenue while posting a solid 18-cent beat in its EPS during Q4. Analysts expect it to continue growing at a decent pace, while Wall-Street believes it is trading <a href="https://www.tipranks.com/stocks/himx/forecast">at a 44% discount</a> to its intrinsic value.



On the date of publication, Muslim Farooque did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Muslim Farooque is a keen investor and an optimist at heart. A life-long gamer and tech enthusiast, he has a particular affinity for analyzing technology stocks. Muslim holds a bachelor&rsquo;s of science degree in applied accounting from Oxford Brookes University.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/what-is-the-best-10-stock-to-buy-in-april-3-top-picks/">What Is the Best $10 Stock to Buy in April? 3 Top Picks</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

What Is the Best $10 Stock to Buy in April? 3 Top Picks

inTest Q1 2024 Earnings Preview

inTest Non-GAAP EPS of $0.10 beats by $0.01, revenue of $29.82M beats by $0.77M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
inTest (NYSEMKT:<a href="https://investorplace.com/stock-quotes/intt-stock-quote/">INTT</a>) just reported results for the first quarter of 2024.<ul><li>inTest reported earnings per share of 10 cents. This was above the analyst estimate for EPS of 9 cents.</li><li>The company reported revenue of $29.82 million.</li><li>This was 2.66% better than the analyst estimate for revenue of $29.05 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/intt-stock-earnings-intest-for-q1-of-2024/">INTT Stock Earnings: inTest Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

INTT Stock Earnings: inTest Beats EPS, Beats Revenue for Q1 2024

inTEST Corporation 2024 Q1 - Results - Earnings Call Presentation

inTEST Corporation (INTT) Q1 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on inTEST (INTT – Research Report), Varonis Systems (VR...

Wall Street Analysts Are Bullish on Top Technology Picks

ACLS

AEHR

GRAB

HIMX

VRNS

Press Releases

inTEST Delays Fourth Quarter and Full Year 2023 Earnings Release and Investor Conference Call; Provides Preliminary Fourth Quarter Results and 2024 Guidance

inTEST to Restate Third Quarter and First Nine Months 2023 Financial Statements

inTEST Expands Electronic Test Capabilities with Acquisition of Alfamation S.p.A.

inTEST Announces Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast

inTEST Reports Record $123.3 Million in Revenue and Net Income of $9.3 Million for Full Year 2023

inTEST Corporation to Present at the LD Micro Invitational Conference

inTEST Schedules First Quarter 2024 Financial Results Conference Call and Webcast

inTEST Corporation Launches Leading-Edge Benchtop Temperature Test System

inTEST Extends Maturity Date of Borrowing Agreement to 2031

inTEST Reports $29.8 Million in Revenue for First Quarter 2024

Axcelis Technologies, Inc. - Common Stock

Axcelis Technologies

ACM Research, Inc. - Class A Common Stock

ACM Research

Aehr Test Systems

Applied Mat

Amkor Tech

ASML Holding N.V. - New York Registry Shares

ASML Holding

Atomera

Cohu

DAQO New Energy Corp. American Depositary Shares, each representing five ordinary shares